Metastatic Pancreatic Ductal Adenocarcinoma
1 competing product in clinical development for Metastatic Pancreatic Ductal Adenocarcinoma.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Autologous Mesothelin-specific TCR-T Cells + Cyclophosphamide + Fludarabine + Bendamustine | Lonza | Phase 1 | Terminated | 30 |